Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer

Chemotherapy

Volumn 56, Issue 1, 2010, Pages 69-70

  Huober, Jens ^a   Schoch, Otto ^b   Templeton, Arnoud ^a   Spirig, Christian ^a   Thürlimann, Beat ^a  

^a Breast Center   (Switzerland)

^b Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DOXORUBICIN; PREDNISONE;

ADULT; BREAST CANCER; CASE REPORT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOXORUBICIN; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; POLYETHYLENE GLYCOLS; RESPIRATORY FUNCTION TESTS; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76049115261     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282286     Document Type: Letter

References (5)

1. Vahid B, Marik PE: Pulmonary complications of novel antineoplastic agents for solid tumors. Chest 2008; 133: 528-538. (Pubitemid 351272414)
2. Di Costanzo F, Mazzoni F, Mela MM, et al: Bevacizumab in non-small cell lung cancer. Drugs 2008; 68: 737-746.
3. Prat A, Martinez P, Serrano C, et al: Acute lung injury associated with docetaxel and bevacizumab. Clin Oncol 2007; 19: 803-805.
4. Vahid B, Mehrota A: Trastuzumab (Herceptin)- associated lung injury. Respirology 2006; 11: 655-658.
5. Navarro C, Ruiz V, Gaxiola M, Carrillo G, et al: Angiogenesis in hypersensitivity pneumonitis. Arch Physiol Biochem 2003; 111: 365-368.